Hoth Therapeutics, Inc. - Common Stock (HOTH)

Hoth Therapeutics (NASDAQHOTH) is at the forefront of developing innovative therapies for unmet medical needs. The company will be presenting alongside world-class headliners such as Zack Kass, former Head of Go-To-Market at OpenAI where ChatGPT was created, and “Shark Tank” stars Kevin O’Leary, Robert Herjavec, and Daymond John.

Hoth Therapeutics, Inc. (NASDAQHOTH) is one today’s most active stocks by volume. So far today, approximately 85.86M shares of Hoth Therapeutics, Inc. have been exchanged, as compared to an average 30-day volume of 242.75k shares.

BALA CYNWYD, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Hoth Therapeutics, Inc. (NasdaqCM: HOTH) with Algorithm Sciences, Inc. pursuant to which Hoth shareholders are currently anticipated to own approximately 14% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Hoth Therapeutics, Inc. (NASDAQHOTH) and Algorithm Sciences, Inc. is fair to Hoth shareholders. Upon completion of the proposed transaction, Hoth shareholders are expected to own approximately 14% of the combined company.

EQNX::TICKER_START (NASDAQSILO),NASDAQ:BXRXNASDAQBXRX)(NASDAQ:HOTHNASDAQHOTH,(NASDAQ:KALANASDAQ),(NASDAQ:NUWENUWE) EQNX::TICKER_END

Hoth Therapeutics, Inc. (NASDAQHOTH) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development

Hoth Therapeutics (NASDAQHOTH), a patient-focused biopharmaceutical company, has announced the pricing of its underwritten public offering. The offering, consisting of 8,235,294 shares of common stock and priced at the market under Nasdaq requirements, is available at a public offering price of $0.85 per share. Based on that information, the offering should result in approximately $7 million gross proceeds for the company, before standard deductions. Hoth plans on using the proceeds from the offering for working capital and general corporate purposes. The announcement also noted that Hoth granted the underwriters a 45-day option to purchase additional shares. According to the announcement, the offering is expected to close today.

Palm Beach, FL –January 4, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease is a degenerative, progressive ailment that attacks the brain’s nerve cells, resulting in memory loss, behavioral changes as well as changes in thinking and language skills. During the COVID-19 outbreak, some of the clinical trials for Alzheimer’s disease were postponed due to […]

Palm Beach, FL –December 21, 2021 – FinancialNewsMedia.com News Commentary – Systemic mastocytosis is rare disease which affects very few people and it causes due to C-kit mutation which leads to higher number of mast cell production in the body resulting in accumulation of excessive mast cells in the internal body organs such as spleen, […]

Palm Beach, FL –December 8, 2021 – FinancialNewsMedia.com News Commentary – Systemic Lupus Erythematosus is also known as lupus. It is an autoimmune disease that affects all parts of your body. The reason for the occurrence of autoimmune disease is because the immune system attacks our body as it perceives it as something foreign. People […]

Palm Beach, FL –November 30, 2021 – FinancialNewsMedia.com News Commentary – Atopic dermatitis is a chronic inflammatory skin condition characterized by red, itchy, swollen, and broken skin. White fluid can leak from the affected region, necessitating treatment. The atopic dermis is more common in children and can become more serious as they get older. Atopic […]

Palm Beach, FL –November 16, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has affected the healthcare systems globally and also has a significant impact on the cancer therapy market. As per the article published in Cancer Connect 2020, doctors from Dana Farber Cancer Institute determined that during the COVID-19 pandemic, there was a […]

Palm Beach, FL –October 12, 2021 – FinancialNewsMedia.com News Commentary – Atopic Dermatitis is an inflammatory skin disease, and the degree of its severity varies from patient to patient. It usually begins in childhood and is mostly confined to the flexural surfaces of the body. It is highly prevalent and is more commonly known as […]